Aviles Ronnier J, Askari Arman T, Lindahl Bertil, Wallentin Lars, Jia Gang, Ohman E Magnus, Mahaffey Kenneth W, Newby L Kristin, Califf Robert M, Simoons Maarten L, Topol Eric J, Berger Peter, Lauer Michael S
Department of Cardiology, the Cleveland Clinic Foundation, Cleveland, OH 44951, USA.
N Engl J Med. 2002 Jun 27;346(26):2047-52. doi: 10.1056/NEJMoa013456.
Among patients with suspected acute coronary syndromes, cardiac troponin T levels have prognostic value. However, there is concern that renal dysfunction may impair the prognostic value, because cardiac troponin T may be cleared by the kidney.
We analyzed the outcomes in 7033 patients enrolled in the Global Use of Strategies to Open Occluded Coronary Arteries IV trial who had complete base-line data on troponin T levels and creatinine clearance rates. The troponin T level was considered abnormal if it was 0.1 ng per milliliter or higher, and creatinine clearance was assessed in quartiles. The primary end point was a composite of death or myocardial infarction within 30 days.
Death or myocardial infarction occurred in 581 patients. Among patients with a creatinine clearance above the 25th percentile value of 58.4 ml per minute, an abnormally elevated troponin T level was predictive of an increased risk of myocardial infarction or death (7 percent vs. 5 percent; adjusted odds ratio, 1.7; 95 percent confidence interval, 1.3 to 2.2; P<0.001). Among patients with a creatinine clearance in the lowest quartile, an elevated troponin T level was similarly predictive of increased risk (20 percent vs. 9 percent; adjusted odds ratio, 2.5; 95 percent confidence interval, 1.8 to 3.3; P<0.001). When the creatinine clearance rate was considered as a continuous variable and age, sex, ST-segment depression, heart failure, previous revascularization, diabetes mellitus, and other confounders had been accounted for, elevation of the troponin T level was independently predictive of risk across the entire spectrum of renal function.
Cardiac troponin T levels predict short-term prognosis in patients with acute coronary syndromes regardless of their level of creatinine clearance.
在疑似急性冠状动脉综合征的患者中,心肌肌钙蛋白T水平具有预后价值。然而,有人担心肾功能不全可能会损害其预后价值,因为心肌肌钙蛋白T可能会被肾脏清除。
我们分析了全球急性冠状动脉闭塞开通策略IV试验中7033例患者的结局,这些患者有关于肌钙蛋白T水平和肌酐清除率的完整基线数据。肌钙蛋白T水平若每毫升0.1纳克或更高则被视为异常,肌酐清除率按四分位数进行评估。主要终点是30天内死亡或心肌梗死的复合终点。
581例患者发生了死亡或心肌梗死。在肌酐清除率高于第25百分位数58.4毫升每分钟的患者中,肌钙蛋白T水平异常升高预示着心肌梗死或死亡风险增加(7%对5%;校正比值比为1.7;95%置信区间为1.3至2.2;P<0.001)。在肌酐清除率处于最低四分位数的患者中,肌钙蛋白T水平升高同样预示着风险增加(20%对9%;校正比值比为2.5;95%置信区间为1.8至3.3;P<0.001)。当将肌酐清除率视为连续变量,并对年龄、性别、ST段压低、心力衰竭、既往血运重建、糖尿病及其他混杂因素进行校正后,肌钙蛋白T水平升高在整个肾功能范围内均独立预示着风险。
无论肌酐清除率水平如何,心肌肌钙蛋白T水平均可预测急性冠状动脉综合征患者的短期预后。